File(s) under permanent embargo
Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial
journal contribution
posted on 2013-11-01, 00:00 authored by R H Grimm, J J McNeil, W Applegate, L Beilin, S Espinoza, C Johnston, B Kirpach, K Margolis, A Murray, M R Nelson, Christopher M. Reid, R Shah, E Storey, A M Tonkin, P Wilson, R Wolfe, Robyn L. Woods, W Abhayaratna, D Ames, L Cobiac, G Donnan, P Gibbs, R Head, H Krum, D Ives, M Jelnik, M Malik, J Williamson, C Eaton, J Weissfeld, F MacRae, L M Rodriguez, A Newman, J Demons, B Workman, E Wood, S Satterfield, J E Lockery, R C Shah, B Radziszewska, A Thomas, Gerard GillGerard Gill, C Jackson, M Kidd, G RussellStudy design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial
History
Journal
CONTEMPORARY CLINICAL TRIALSVolume
36Issue
2Pagination
555 - 564Publisher
ELSEVIER SCIENCE INCPublisher DOI
ISSN
1551-7144eISSN
1559-2030Language
EnglishPublication classification
C Journal article; C1.1 Refereed article in a scholarly journalCopyright notice
2013, Elsevier Inc.Usage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineMedicine, Research & ExperimentalPharmacology & PharmacyResearch & Experimental MedicineAspirinClinical trialAgingDementiaDisabilityPrimary preventionLOW-DOSE ASPIRINALZHEIMER-DISEASEAFRICAN-AMERICANSASSOCIATIONRELIABILITYASPREE Investigator GroupCLINICAL-TRIALSRISKPEOPLE